Irinotecan topoisomerase 1 inhibitor
WebIrinotecan (CPT-11, (+)-Irinotecan) is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively. CAS No. 97682-44-5 Selleck's Irinotecan (CPT-11) has been cited by publications Cell Death Dis,202414 (1):64 Cancers (Basel),202414 (5)1230 Oncotarget,202413:1094-1108 Cell Death Discov,20248 (1):296 WebDec 1, 1997 · Abstract. Topoisomerase I inhibitors are a new class of anticancer agents with a mechanism of action aimed at interrupting DNA replication in cancer cells, the result of …
Irinotecan topoisomerase 1 inhibitor
Did you know?
WebIrinotecan (CPT-11, (+)-Irinotecan) is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively. Camptothecin (NSC-100880) Camptothecin (NSC-100880, CPT, Campathecin, (S)- (+)-Camptothecin) is a specific inhibitor of DNA topoisomerase I (Topo I) with IC50 of 0.68 μM in a cell-free assay. WebAug 17, 2024 · BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors in Patients With Advanced Solid Tumors, Phase I Studies With Expansion Cohorts in Small Cell Lung …
WebFeb 13, 2024 · Irinotecan (SN-38) is a potent and broad-spectrum anticancer drug that targets DNA topoisomerase I (Top1). It exerts its cytotoxic effects by binding to the Top1-DNA complex and preventing the re-ligation of the DNA strand, leading to the formation of lethal DNA breaks. Following the initial response to irinotecan, secondary resistance is … WebNov 4, 2024 · Irinotecan is a topoisomerase I inhibitor used to treat several solid tumor types, especially in combination with other chemotherapeutic agents in the treatment of colorectal cancer. Irinotecan combined with 5-fluorouracil (5FU) is widely used in the treatment of colorectal cancer. [ 1] Inhibition of topoisomerase I by irinotecan and its …
WebTopoisomerase inhibitors block the ligation step of the cell cycle, which generates DNA single- and double-strand breaks, leading to apoptotic cell death. Topoisomerase I … WebNov 22, 2011 · The topoisomerase I (Top 1) poison irinotecan is an important component of the modern treatment of colorectal cancer. By stabilising Top 1-DNA complexes, …
WebIrinotecan hydrochloride injection is an antineoplastic agent of the topoisomerase I inhibitor class. Irinotecan hydrochloride injection is supplied as a sterile, pale yellow, clear, aqueous solution. Each milliliter of solution contains 20 mg of irinotecan hydrochloride (on the basis of the trihydrate salt), 45 mg of sorbitol, NF, and 0.9 mg ...
Webmer conjugate of irinotecan, a topoisomerase 1 (Top1) inhibitor, designed to provide continuous exposure of SN38 in tumors while avoiding high irinotecan and SN38 plasma concentrations that lead to high AUCs associated with unwanted side effects [10]. Etirinotecan pegol uses propri-etary polymer conjugation with large-chain polyethylene sbs tv app downloadWebApr 13, 2024 · This is a review article about resistance to irinotecan (SN-38). A review on irinotecan (and other TOP1-targeting drugs) should be very helpful, as these widely used drugs no longer enjoy the literature attention that they used to have. ... Some topoisomerase inhibitors that are not poisons inhibit the activity by acting at steps other than DNA ... sbs tv networkWebJul 31, 2024 · Topoisomerase I inhibitor, irinotecan, depletes regulatory T cells and up-regulates MHC class I and PD-L1 expression, resulting in a supra-additive antitumor … sbs tv scheduleWebDrug Description. Irinotecan. An antineoplastic enzyme inhibitor used to treat metastatic carcinoma of the colon or rectum. Topotecan. An antineoplastic agent used to treat … sbs tv live stream onlinesbs tv fifa world cupWebTopoisomerase inhibitors are used to treat various types of cancer, such as colon cancer, leukemia, ovarian, and small-cell lung cancer. Common side effects of topoisomerase inhibitors include fatigue, gastrointestinal problems like diarrhea, hair loss, anemia, and increased risk of infection. Some patients may also experience more severe side ... sbs tv programme tonightWebSep 21, 2016 · Therefore, topoisomerase 1 inhibitors are reasonable therapeutic options for recurrent GBM after failure of alkylating agents. Topoisomerase 1 inhibitors have excellent penetration through the blood-brain barrier, but the treatment results for glioblastomas have been disappointing. sbs tv online free